Rob Masella is a senior partner in the Mergers & Acquisitions Group at Shearman & Sterling LLP and the Head of the Firm’s Healthcare Group.
Rob’s transactional work in healthcare includes mergers and acquisitions, sell-side and buy-side transactions, dual-track M&A/IPO processes, strategic alliances, licenses, co-promotion agreements and other forms of corporate transactions. He has worked on a number of notable US and cross-border transactions, with several deals receiving the “Global M&A Deal of the Year Award” by the American Lawyer. Rob’s corporate governance practice includes advising clients with respect to shareholder activism, corporate governance and fiduciary duty matters, and risk management.
Prior to joining Shearman & Sterling, Rob spent a number of years as a Managing Director in the Mergers & Acquisitions Group at Bank of America Merrill Lynch, where he advised companies on both friendly and unsolicited transactions, and was a member of the firm’s fairness opinion committee. He previously was with Cravath, Swaine & Moore for nearly a decade.
Rob is a member of the New York Bar Association’s Committee on Mergers & Acquisitions and Corporate Control Contests, a member of the Corporate Governance Advisory Board of Thomson Reuters and a member of Law 360’s Life Sciences Editorial Advisory Board. He sits on the National Advisory Committee of the Colonial Williamsburg Foundation and leads a program with Friends of Rockaway for Hurricane Sandy relief.
Rob earned a BA in economics from the College of William & Mary, a GC in international economics from the London School of Economics and a JD/MBA from the University of Pennsylvania.